GAIN THERAPEUTICS, INC Pension Expense (Reversal of Expense), Noncash
GAIN THERAPEUTICS, INC (GANX) reported Pension Expense (Reversal of Expense), Noncash of $55.33 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:PensionExpenseReversalOfExpenseNoncash · last filed 2022-03-25
- GAIN THERAPEUTICS, INC pension expense (reversal of expense), noncash for the quarter ending 2021-12-31 was $10.39K, a 383.53% increase year-over-year.
- GAIN THERAPEUTICS, INC pension expense (reversal of expense), noncash for the quarter ending 2021-09-30 was $20.23K.
- GAIN THERAPEUTICS, INC pension expense (reversal of expense), noncash for the quarter ending 2020-12-31 was $2.15K.
- GAIN THERAPEUTICS, INC pension expense (reversal of expense), noncash for the quarter ending 2020-09-30 was -$4.59K.
- GAIN THERAPEUTICS, INC pension expense (reversal of expense), noncash for fiscal 2021 was $55.33K, a 535.27% increase from fiscal 2020.
- GAIN THERAPEUTICS, INC pension expense (reversal of expense), noncash for fiscal 2020 was $8.71K.
| Period end | Pension Expense (Reversal of Expense), Noncash 3 month | Pension Expense (Reversal of Expense), Noncash 6 month | Pension Expense (Reversal of Expense), Noncash 9 month | Pension Expense (Reversal of Expense), Noncash 12 month |
|---|---|---|---|---|
| 2021-12-31 | $10.39K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $30.63K derived: sum of 2 quarters · filed 2022-03-25 | $55.33K 10-K · filed 2022-03-25 | |
| 2021-09-30 | $20.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $44.94K 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | $24.70K 10-Q · filed 2021-08-12 | |||
| 2020-12-31 | $2.15K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | -$2.44K derived: sum of 2 quarters · filed 2022-03-25 | $8.71K 10-K · filed 2022-03-25 | |
| 2020-09-30 | -$4.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $6.56K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $11.15K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |